Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

BBIOBBIO
10 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in BRIDGEBIO PHARMA INC

FARALLON CAPITAL MANAGEMENT, L.L.C. holds 10.7M shares of BBIO (BRIDGEBIO PHARMA INC), worth $800.1M as of 2026-Q2. The position was increased (+14.7% shares). BBIO represents 3.7% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.

Current Value

$800.1M

Current Shares

10.7M

Total Value Change

+$799.9M

Total Shares Change

+10.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
10.7M
+14.7%
$800.1M3.7%$74.48
67
2026-Q1
Increased
9.4M
+4.1%
$695.5M3.6%$74.26
60
2025-Q4
Increased
9M
+9.8%
$688.3M3.0%$76.49
60
2025-Q3
Increased
8.2M
+3.7%
$425.5M1.7%$51.94
51
2025-Q2
Increased
7.9M
+37.9%
$341.1M1.4%$43.18
64
2025-Q1
Increased
5.7M
+36.6%
$198.1M1.0%$34.57
56
2024-Q4
Increased
4.2M
+140.1%
$115.1M0.5%$27.44
68
2024-Q3
New
1.7M
-
$44.5M0.2%$25.46
48
2024-Q1
Exited
0
-100.0%
$00.0%$30.92
0
2023-Q4
New
6,000
-
$242,2200.0%$40.37
32

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used